-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Verastem, Raises Price Target to $19

Benzinga·10/15/2026 15:01:56
語音播報
RBC Capital analyst Leonid Timashev maintains Verastem (NASDAQ:VSTM) with a Outperform and raises the price target from $14 to $19.